Pramiracetam

CAS No. 68497-62-1

Pramiracetam( CI-879 )

Catalog No. M15617 CAS No. 68497-62-1

A central nervous system stimulant and nootropic agent; shows cognition-restoring and neuroprotective properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
50MG 35 In Stock
100MG 54 In Stock
200MG 86 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pramiracetam
  • Note
    Research use only, not for human use.
  • Brief Description
    A central nervous system stimulant and nootropic agent; shows cognition-restoring and neuroprotective properties.
  • Description
    A central nervous system stimulant and nootropic agent; shows cognition-restoring and neuroprotective properties.Other Indication Approved.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Male Long Evans hooded rats (250-300 g)Dosage:7.5, 15 mg/kg Administration:i.p.Result:Improved performance in the reference memory component of the task, but did not significantly affect the working memory component.
  • Synonyms
    CI-879
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    68497-62-1
  • Formula Weight
    269.3831
  • Molecular Formula
    C14H27N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C
  • Chemical Name
    1-Pyrrolidineacetamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Substance P-methyl e...

    Substance P, [Met-OMet11] is a selective SP-P agonist. Substance P, [Met-OMet11] also is an active peptide. Substance P, [Met-OMet11] can be used for various biochemical studies.

  • GW6340

    GW6340 is a selective LXR agonist with potential anticancer activity that promotes macrophage reverse cholesterol transport (mRCT) and can be used to study atherosclerosis.

  • 22393-62-0_peak 2

    22393-62-0_peak 2 exhibits some aspects of the antiestrogenic activity and other actions that may be connected to the estrogenic properties.